FIELD: chemistry.
SUBSTANCE: invention relates to crystalline forms of (R)-5-[3-chloro-4-(2, 3-dihydroxypropoxy)bez[z]iliden]-2-([z]-propylimino)-3-o-tolylthiazolidin-4-one, methods of their obtaining, pharmaceutical composition, containing said crystalline forms, and application of said forms as compounds, improving vascular function, and as immunomodulatory agents.
EFFECT: obtaining compounds, improving vascular function.
22 cl, 5 dwg, 5 tbl, 7 ex
| Title |
Year |
Author |
Number |
| NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT |
2004 |
- Blasko Andrej
- Tszin' Tsinvu
- Lu Tsjun'
- Morejdzhis Majkl Ehntoni
- Song Dong
- Vondervell Brenda S'Ju
|
RU2319702C2 |
| POLYMORPHIC FORM OF N-[(R)-2,3-DIHYDROXYPROPOXY]-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)BENZAMIDE |
2004 |
- Matsikenas Dajnius
- Nanninga Tomas
|
RU2352558C2 |
| DERIVATIVES OF 5-(BENZ-(Z)-YLIDENE)THIAZOLIDINE-4-ONE AND APPLICATION THEREOF AS IMMUNOSUPPRESSIVE AGENTS |
2004 |
- Bolli Martin
- Sherts Majkl
- Mjuller Klaus
- Matis Boris
- Binkert Kristof
- Najler Oliver
|
RU2379299C2 |
| 4-[2-[[5-METHYL-1-(2-NAPHTHALINYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE POLYMORPH AND SOLVATES |
2011 |
- Berenger Majmo Ramon
- Medrano Ruperes Khorkhe
- Benet Bukhkhol'Ts Khordi
- Puig Fernandes Laura
- Pellekha Pukseu Laja
|
RU2560150C2 |
| NOVEL CRYSTALLINE FORMS OF SODIUM SALT OF (4-{4-[5-(6-TRIFLUOROMETHYL-PYRIDIN-3-YLAMINO)PYRIDIN-2-YL]PHENYL}CYCLOHEXYL) ACETIC ACID |
2011 |
|
RU2612556C2 |
| CRYSTALLINE FORM OF (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[b]THIOPHENE-2-CARBOXAMIDE HYDROCHLORIDE MONOHYDRATE |
2011 |
- Oliver-Sheffer Patrisija
- Shapiro Gideon
- Chesuort Richard
- Kisida Muneki
- Isige Takajuki
|
RU2577334C2 |
| MALEATE SALTS OF (E)-N-{4-[3-CHLORO-4-(2-PYRIDINYLMETHOXY)ANILINO]-3-CYANO-7-ETHOXY-6-QUINOLINYL}-4-(DIMETHYLAMINO)-2-BUTENAMIDE AND THEIR CRYSTALLINE FORMS |
2017 |
- Mirmehrabi Mahmoud
- Cheal Gloria K.
- Chew Warren
- Hadfield Anthony F.
- Ku Mannching Sherry
- Lu Qinghong
|
RU2807142C1 |
| -N-{4-[3-CHLOR-4-(2-PYRIDINYLMETHOXY)ANILINO]-3-CYANO-7-ETHOXY-6-QUINOLINYL}-4-(DIMETHYLAMINO)-2-BUTENAMIDE MALEATE SALTS AND THEIR CRYSTALLINE FORMS |
2008 |
- Lu Kingkhong
- Ku Mannching Sherri
- Chu Uorren
- Chil Glorija K.
- Khehdfild Ehntoni F.
- Mirmekhrabi Makhmud
|
RU2463300C2 |
| CRYSTALLINE FUMARATE SALT OF (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)PHENYL][3-HYDROXY-3-(PIPERIDINE-2-YL)AZETIDINE-1-YL]METHANONE |
2016 |
|
RU2762181C2 |
| (1R*,2R*,4R*)-2-(2-{[3(4,7-DIMETHOXY-1H-BENZOIMIDAZOL-2-YL)PROPYL]METHYLAMINO}ETHYL)-5-PHENYLBICYCLO[2,2,2]OCT-5-EN-2-YL ISOBUTYRIC ACID SALTS |
2009 |
- Shtefan Abele
- Stefani Kombe
- Zhak-Aleksis Fjunel'
- Kurt Khil'Pert
- Fransis Juble
- Katarina Rajkhenbehkher
- Dorte Renneberg
- Markus Fon Raumer
|
RU2516247C2 |
